Page last updated: 2024-10-28

gyki 52466 and Chronic Illness

gyki 52466 has been researched along with Chronic Illness in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kim, JE1
Park, H1
Lee, JE1
Kim, TH1
Kang, TC1
Farley, S1
Apazoglou, K1
Witkin, JM1
Giros, B1
Tzavara, ET1

Other Studies

2 other studies available for gyki 52466 and Chronic Illness

ArticleYear
PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats.
    International journal of molecular sciences, 2020, Aug-06, Volume: 21, Issue:16

    Topics: Animals; Benzodiazepines; Chronic Disease; Down-Regulation; Epilepsy; Hippocampus; Male; Models, Bio

2020
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:9

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depr

2010